中国综合临床
中國綜閤臨床
중국종합림상
Clinical Medicine of China
2015年
9期
772-777
,共6页
饥饿素%肝星状细胞%血小板源生长因子BB%肝纤维化%前胶原Ⅰ%α平滑肌肌动蛋白%PI3K-AKT通路
饑餓素%肝星狀細胞%血小闆源生長因子BB%肝纖維化%前膠原Ⅰ%α平滑肌肌動蛋白%PI3K-AKT通路
기아소%간성상세포%혈소판원생장인자BB%간섬유화%전효원Ⅰ%α평활기기동단백%PI3K-AKT통로
Ghrelin%Hepatic stellate cell%Platelet-derived growth factor-BB%Liver fibrosis%Procollagen type Ⅰ%Alpha smooth muscle actin%PI3K-AKT pathway
目的 观察饥饿素(Ghrelin)对血小板源生长因子BB(PDGF-BB)刺激后体外培养人肝星状细胞(HSC-LX2)前胶原Ⅰ(procollagen type Ⅰ)合成及α平滑肌肌动蛋白(α-SMA)生成的影响,同时探讨PI3K-AKT通路在其中发挥的作用.方法 依不同浓度饥饿素与PDGF联合干预,以及设立空白对照分为6组:空白对照组、0.10 μmol/L饥饿素组、10 μg/L PDGF组、0.05 μmol/L饥饿素+10 μg/L PDGF组、0.10 μmol/L饥饿素+10 μg/L PDGF组、0.15 μmol/L饥饿素+10 μg/L PDGF组.体外培养HSC-LX2,分别行饥饿素、PDGF干预和两者按饥饿素不同浓度共同干预细胞.采用定量PCR方法检测各组前胶原Ⅰ mRNA,Western blot方法检测相应组别α-SMA以及AKT的表达变化.PI3K特异性抑制剂LY294002预处理LX2细胞以阻断PI3K-AKT通路,分为3组:PDGF组、饥饿素+PDGF组以及LY294002+饥饿素+PDGF组.采用定量PCR法检测各组前胶原Ⅰ mRNA及Western blot法检测α-SMA表达变化.结果 定量PCR结果显示,PDGF组前胶原Ⅰ mRNA为(6.91±0.46),较空白对照组(1.00±0.08)明显升高(P<0.05).饥饿素组前胶原Ⅰ mRNA为(0.60±0.13),与空白对照组比较差异无统计学意义(P>0.05).不同浓度饥饿素+PDGF共同处理组前胶原Ⅰ mRNA表达(依次为:3.11±0.28、2.03±0.23、0.70±0.06)与PDGF组比较显著降低,差异均有统计学意义(P均<0.05),且随饥饿素浓度的增加其抑制作用增强,呈浓度依赖性关系.Western blot结果显示,饥饿素+PDGF组α-SMA较PDGF组表达降低.饥饿素+PDGF组AKT表达较PDGF组上调,提示PI3K-AKT可能参与了饥饿素对LX2细胞抗纤维化作用的调节.PI3K特异性抑制剂拮抗PI3K-AKT预处理后,LY 294002+饥饿素+PDGF组前胶原Ⅰ mRNA为(4.13±0.21),较饥饿素+PDGF组(2.34±0.25)明显上升(P<0.05);Western blot结果亦显示α-SMA表达水平前者较后者明显升高,提示PI3K阻断后,饥饿素的抗纤维化作用下调.结论 PDGF刺激肝星状细胞活化后,饥饿素通过激活PI3K-AKT通路抑制前胶原Ⅰ及α-SMA生成从而发挥抗肝纤维化作用,可能成为今后防治肝纤维化的新途径.
目的 觀察饑餓素(Ghrelin)對血小闆源生長因子BB(PDGF-BB)刺激後體外培養人肝星狀細胞(HSC-LX2)前膠原Ⅰ(procollagen type Ⅰ)閤成及α平滑肌肌動蛋白(α-SMA)生成的影響,同時探討PI3K-AKT通路在其中髮揮的作用.方法 依不同濃度饑餓素與PDGF聯閤榦預,以及設立空白對照分為6組:空白對照組、0.10 μmol/L饑餓素組、10 μg/L PDGF組、0.05 μmol/L饑餓素+10 μg/L PDGF組、0.10 μmol/L饑餓素+10 μg/L PDGF組、0.15 μmol/L饑餓素+10 μg/L PDGF組.體外培養HSC-LX2,分彆行饑餓素、PDGF榦預和兩者按饑餓素不同濃度共同榦預細胞.採用定量PCR方法檢測各組前膠原Ⅰ mRNA,Western blot方法檢測相應組彆α-SMA以及AKT的錶達變化.PI3K特異性抑製劑LY294002預處理LX2細胞以阻斷PI3K-AKT通路,分為3組:PDGF組、饑餓素+PDGF組以及LY294002+饑餓素+PDGF組.採用定量PCR法檢測各組前膠原Ⅰ mRNA及Western blot法檢測α-SMA錶達變化.結果 定量PCR結果顯示,PDGF組前膠原Ⅰ mRNA為(6.91±0.46),較空白對照組(1.00±0.08)明顯升高(P<0.05).饑餓素組前膠原Ⅰ mRNA為(0.60±0.13),與空白對照組比較差異無統計學意義(P>0.05).不同濃度饑餓素+PDGF共同處理組前膠原Ⅰ mRNA錶達(依次為:3.11±0.28、2.03±0.23、0.70±0.06)與PDGF組比較顯著降低,差異均有統計學意義(P均<0.05),且隨饑餓素濃度的增加其抑製作用增彊,呈濃度依賴性關繫.Western blot結果顯示,饑餓素+PDGF組α-SMA較PDGF組錶達降低.饑餓素+PDGF組AKT錶達較PDGF組上調,提示PI3K-AKT可能參與瞭饑餓素對LX2細胞抗纖維化作用的調節.PI3K特異性抑製劑拮抗PI3K-AKT預處理後,LY 294002+饑餓素+PDGF組前膠原Ⅰ mRNA為(4.13±0.21),較饑餓素+PDGF組(2.34±0.25)明顯上升(P<0.05);Western blot結果亦顯示α-SMA錶達水平前者較後者明顯升高,提示PI3K阻斷後,饑餓素的抗纖維化作用下調.結論 PDGF刺激肝星狀細胞活化後,饑餓素通過激活PI3K-AKT通路抑製前膠原Ⅰ及α-SMA生成從而髮揮抗肝纖維化作用,可能成為今後防治肝纖維化的新途徑.
목적 관찰기아소(Ghrelin)대혈소판원생장인자BB(PDGF-BB)자격후체외배양인간성상세포(HSC-LX2)전효원Ⅰ(procollagen type Ⅰ)합성급α평활기기동단백(α-SMA)생성적영향,동시탐토PI3K-AKT통로재기중발휘적작용.방법 의불동농도기아소여PDGF연합간예,이급설립공백대조분위6조:공백대조조、0.10 μmol/L기아소조、10 μg/L PDGF조、0.05 μmol/L기아소+10 μg/L PDGF조、0.10 μmol/L기아소+10 μg/L PDGF조、0.15 μmol/L기아소+10 μg/L PDGF조.체외배양HSC-LX2,분별행기아소、PDGF간예화량자안기아소불동농도공동간예세포.채용정량PCR방법검측각조전효원Ⅰ mRNA,Western blot방법검측상응조별α-SMA이급AKT적표체변화.PI3K특이성억제제LY294002예처리LX2세포이조단PI3K-AKT통로,분위3조:PDGF조、기아소+PDGF조이급LY294002+기아소+PDGF조.채용정량PCR법검측각조전효원Ⅰ mRNA급Western blot법검측α-SMA표체변화.결과 정량PCR결과현시,PDGF조전효원Ⅰ mRNA위(6.91±0.46),교공백대조조(1.00±0.08)명현승고(P<0.05).기아소조전효원Ⅰ mRNA위(0.60±0.13),여공백대조조비교차이무통계학의의(P>0.05).불동농도기아소+PDGF공동처리조전효원Ⅰ mRNA표체(의차위:3.11±0.28、2.03±0.23、0.70±0.06)여PDGF조비교현저강저,차이균유통계학의의(P균<0.05),차수기아소농도적증가기억제작용증강,정농도의뢰성관계.Western blot결과현시,기아소+PDGF조α-SMA교PDGF조표체강저.기아소+PDGF조AKT표체교PDGF조상조,제시PI3K-AKT가능삼여료기아소대LX2세포항섬유화작용적조절.PI3K특이성억제제길항PI3K-AKT예처리후,LY 294002+기아소+PDGF조전효원Ⅰ mRNA위(4.13±0.21),교기아소+PDGF조(2.34±0.25)명현상승(P<0.05);Western blot결과역현시α-SMA표체수평전자교후자명현승고,제시PI3K조단후,기아소적항섬유화작용하조.결론 PDGF자격간성상세포활화후,기아소통과격활PI3K-AKT통로억제전효원Ⅰ급α-SMA생성종이발휘항간섬유화작용,가능성위금후방치간섬유화적신도경.
Objective To observe the effect of ghrelin on the expression of procollagen type Ⅰ and alpha smooth muscle actin (α-SMA) synthesis in vitro cultured human hepatic stellate cell (HSC-LX2) stimulated by Platelet-derived growth factor-BB (PDGF-BB).Besides,the effect of PI3K-AKT pathway was studied.Methods Cultured LX2 were intervented and jointing intervented according to the different ghrelin concentration by ghrelin and PDGF:control group,0.1 μmol/L Ghrelin group,10 μg/L PDGF group,0.05 μmol/L Ghrelin +10 μg/L PDGF group,0.1 μmol/L Ghrelin + 10 μg/L PDGF group,0.15 μmol/L Ghrelin + 10 μg/L PDGF group.Culture HSC-LX2 in vitro,joint intervention cells with different concentrations.Procollagen Ⅰ mRNA expression were detected by Polymerase chain reaction (PCR),besides,α-SMA and AKT expression were detected by Western blot in each groups.After treatment by PI3K specific inhibitor LY294002 in LX2,three groups were divided into PDGF,Ghrelin + PDGF and LY294002 + Ghrelin +PDGF.Procollagen Ⅰ mRNA expression were detected by PCR,and α-SMA was detected by Western blot.Results PCR results showed that procollagen Ⅰ expression in PDGF treated group was significantly higher than the control group ((6.91 ± 0.46) vs.(1.00 ± 0.08),P < 0.05),so PDGF can promote the expression of procollagen type Ⅰ.Procollagen Ⅰ mRNA expression between ghrelin group(0.60±0.13) and blank control group had no significant change(P>0.05).Procollagen Ⅰ mRNA expression between different concentrations of Ghrelin and PDGF (3.11 ± 0.28,2.03 ±0.23,0.70 ± 0.06) was significantly reduced than PDGF group.The difference was statistically significant (P <0.05),and with the increase of the ghrelin concentration of the inhibition,the effect was more obvious in a concentration dependent manner.Western blot showed that α-SMA expression was lower in Ghrelin +PDGF group than PDGF group.AKT expression was higher in Ghrelin +PDGF group than PDGF group,indicating that PI3K-AKT may participate in the anti-fibrosis effect of ghrelin in LX2.After treatment of PI3K specific inhibitor,procollagen Ⅰ expression in LY294002+Ghrelin +PDGF group was significantly higher than Ghrelin +PDGF group((4.13±0.21) vs.(2.34±0.25),P<0.05).Western blot also showed that α-SMA expression was higher in LY294002 + Ghrelin + PDGF group than Ghrelin + PDGF group.It was suggested that after inhibitation of PI3K,the anti-fibrosis effect of ghrelin in LX2 was attenuated.Conclusion After stimulated by PDGF in hepatic stellate cell,ghrelin can inhibit procollagen type Ⅰ and alpha-SMA synthesis in the process of hepatic fibrosis via PI3K-AKT pathway,thus,ghrelin may become one of the new ways of prevention and treatment of liver fibrosis.